Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
JAMA
; 331(13): 1135-1144, 2024 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563834
2.
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Breast Cancer Res
; 25(1): 53, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37161532
3.
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
BMC Cancer
; 22(1): 165, 2022 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35151276
4.
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.
Cancers (Basel)
; 16(1)2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201455
5.
Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer.
Sci Rep
; 10(1): 22292, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33339858
6.
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
Sci Rep
; 8(1): 6574, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700408
7.
Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis.
Transl Oncol
; 10(5): 854-866, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886403
8.
Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix-assisted laser desorption/ionisation-time of flight and matrix-assisted laser desorption/ionisation-time of flight/time of flight-mass spectrometry.
Proteomics
; 5(10): 2680-8, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15892168